Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Undiscovered Gems With Strong Fundamentals To Watch This November 2024

In This Article:

As global markets react to a significant political shift in the United States, with the so-called "red sweep" fueling optimism for economic growth and tax reforms, small-cap stocks have captured attention by leading gains, evidenced by the Russell 2000 Index's notable surge. Amidst these developments, investors are increasingly on the lookout for undiscovered gems with robust fundamentals that can capitalize on favorable market conditions; such stocks often exhibit strong financial health and resilience to navigate uncertainties effectively.

Top 10 Undiscovered Gems With Strong Fundamentals

Name

Debt To Equity

Revenue Growth

Earnings Growth

Health Rating

C&D Property Management Group

1.32%

37.15%

41.55%

★★★★★★

Morris State Bancshares

17.84%

4.83%

6.58%

★★★★★★

Impellam Group

31.12%

-5.43%

-6.86%

★★★★★★

Ovostar Union

0.01%

10.19%

49.85%

★★★★★★

Tianyun International Holdings

10.09%

-5.59%

-9.92%

★★★★★★

MAPFRE Middlesea

NA

14.56%

1.77%

★★★★★☆

Bakrie & Brothers

22.66%

7.78%

13.50%

★★★★★☆

A2B Australia

15.83%

-7.78%

25.44%

★★★★☆☆

Wilson

64.79%

30.09%

68.29%

★★★★☆☆

Practic

NA

3.63%

6.85%

★★★★☆☆

Click here to see the full list of 4643 stocks from our Undiscovered Gems With Strong Fundamentals screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Niva Bupa Health Insurance

Simply Wall St Value Rating: ★★★★☆☆

Overview: Niva Bupa Health Insurance Company Limited offers a range of health insurance products in India and has a market capitalization of ₹130.19 billion.

Operations: The primary revenue stream for Niva Bupa comes from its health insurance segment, generating ₹40.01 billion, with additional contributions from travel and personal accident insurance at ₹81.90 million and ₹766.45 million respectively.

Niva Bupa Health Insurance, a relatively small player in the insurance sector, has shown promise by becoming profitable this year. Its interest payments are well covered with an EBIT coverage of 6.1 times, indicating strong financial health. Despite a debt-to-equity ratio increase to 8.4% over five years, it holds more cash than total debt, suggesting prudent financial management. Recent partnerships with AU Small Finance Bank aim to broaden its customer base through extensive distribution across India’s 2,414 touchpoints. However, the company reported a net loss of INR 188 million for Q1 2024 but improved from INR 722 million last year.

NSEI:NIVABUPA Earnings and Revenue Growth as at Nov 2024
NSEI:NIVABUPA Earnings and Revenue Growth as at Nov 2024

Nanjing Well Pharmaceutical GroupLtd

Simply Wall St Value Rating: ★★★★★☆